MindMed Onboards Javier A. Muniz M.D. As Vice President of R&D Strategy
Mind Medicine (MindMed) Inc, a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, recently announced the appointment of Javier A. Muniz, M.D., as Vice President of Research and Development (R&D) Strategy. In his new role, Dr. Muniz will drive innovation and growth of MindMed’s R&D operations as the Company prepares to […]
SamanTree Medical Receives FDA Clearance for Histolog Scanner, Transforming Tissue Imaging in the US
SamanTree Medical, a leader in innovative surgical imaging solutions, recently announced that it has received FDA 510(k) clearance for its Histolog® Scanner for imaging the internal microstructure of tissues including, but not limited to, the identification of cells, vessels and their organization or architecture. This groundbreaking Swiss-made device is designed to provide real-time, high-resolution imaging […]
Aurinia unveils Positive CHMP Opinion for LUPKYNIS in Europe
Aurinia Pharmaceuticals Inc.(Aurinia or the Company), a biopharmaceutical company committed to delivering therapeutics that change the course of autoimmune disease, recently announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending voclosporin (brand name, LUPKYNIS) for marketing authorization to treat adults with active […]
US FDA Permits Covid -19 Booster Dose From PFizer and BioNtech
Pfizer Inc. and BioNTech SE today announced that the U.S. Food and Drug Administration (FDA) has authorized for emergency use a booster dose of the Pfizer-BioNTech COVID-19 Vaccine for individuals 65 years of age and older, individuals 18 through 64 years of age at high risk of severe COVID-19, and individuals 18 through 64 years […]
